Overview
Survival Analysis; Longitudinal Analysis; Joint Modeling; Prediction Modeling and Metrics; Biomarkers; Applications in Pulmonology and Lung Transplant; Statistical Education
Current Appointments & Affiliations
Associate Professor of Biostatistics & Bioinformatics
·
2024 - Present
Biostatistics & Bioinformatics, Division of Biostatistics,
Biostatistics & Bioinformatics
Member in the Duke Clinical Research Institute
·
2011 - Present
Duke Clinical Research Institute,
Institutes and Centers
Recent Publications
Workplace Productivity Loss in Patients with Progressive Pulmonary Fibrosis: Data from the ILD-PRO Registry.
Journal Article Lung · May 27, 2026 PURPOSE: Pulmonary fibrosis may impair an individual's ability to work. We assessed the extent, cost and factors associated with workplace productivity loss among patients with progressive pulmonary fibrosis (PPF). METHODS: The multi-center ILD-PRO Registr ... Full text Link to item CiteTiming is everything: Using time-varying binary indicators for evaluating post-transplant risk factors.
Journal Article J Heart Lung Transplant · April 12, 2026 Risk factors often emerge after transplantation, yet many analyses treat them as fixed at the time of transplant, producing inaccurate or counterintuitive results due to immortal time bias. Using infection‑related hospitalizations after heart transplantati ... Full text Link to item CiteReduced lung fluid club cell secretory protein informs chronic lung allograft dysfunction risk.
Journal Article Eur Respir J · April 2026 BACKGROUND: Lung transplant recipients with lower club cell secretory protein (CCSP) levels in bronchoalveolar lavage fluid (BALF) early post-transplantation are at increased risk for chronic lung allograft dysfunction (CLAD). For CLAD risk stratification, ... Full text Link to item CiteRecent Grants
Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations (INSPIRE-COPD-E).
ResearchAdvisor · Awarded by National Institutes of Health · 2025 - 2030Lung Transplant Clinical Trial Network (LT-CTN)
ResearchStatistical Investigator · Awarded by National Institutes of Health · 2021 - 2028Complement Pathway Activation in Idiopathic Pulmonary Fibrosis and other Progressive Fibrosing Interstitial Lung Diseases (K23)
ResearchCo-Mentor · Awarded by National Heart, Lung, and Blood Institute · 2023 - 2028View All Grants
Education
North Carolina State University ·
2011
Ph.D.